Elsevier

Journal of Critical Care

Volume 68, April 2022, Pages 169-171
Journal of Critical Care

Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients

https://doi.org/10.1016/j.jcrc.2021.11.001Get rights and content

Keywords

COVID-19
Immunotherapy
Tocilizumab
IL-6

Cited by (0)

1

Full list of investigators is available at the end of the article, [email protected]

View Abstract